Lingxiang Wu

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Venues

Leukemia

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Min Wu, Tingting Wang, Nan Ji, Ting Lu, Ran Yuan, Lingxiang Wu, Junxia Zhang, Mengyuan Li, Penghui Cao, Jiarui Zhao, Guanzhang Li, Jianyu Li, Yu Li, Yujie Tang, Zhengliang Gao, Xiuxing Wang, Wen Cheng, Ming Ge, Gang Cui, Rui Li, Anhua Wu, Yongping You, Wei Zhang, Qiang-Hu Wang, Jian Chen
Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nature communications 15 (1) (2024)
Min Wu, Tingting Wang, Nan Ji, Ting Lu, Ran Yuan, Lingxiang Wu, Junxia Zhang, Mengyuan Li, Penghui Cao, Jiarui Zhao, Guanzhang Li, Jianyu Li, Yu Li, Yujie Tang, Zhengliang Gao, Xiuxing Wang, Wen Cheng, Ming Ge, Gang Cui, Rui Li, Anhua Wu, Yongping You, Wei Zhang, Qiang-Hu Wang, Jian Chen
Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nature communications 15 (1) (2024)
Min Wu, Tingting Wang, Nan Ji, Ting Lu, Ran Yuan, Lingxiang Wu, Junxia Zhang, Mengyuan Li, Penghui Cao, Jiarui Zhao, Guanzhang Li, Jianyu Li, Yu Li, Yujie Tang, Zhengliang Gao, Xiuxing Wang, Wen Cheng, Ming Ge, Gang Cui, Rui Li, Anhua Wu, Yongping You, Wei Zhang, Qiang-Hu Wang, Jian Chen
Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nature communications 15 (1) (2024)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia (2022)

Lingxiang Wu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lingxiang Wu